Timothy M. Cox - Concepedia

Author

Timothy M. Cox

University of Cambridge ORCID

Also Known As

A. Chakrapani, Cox, TM, Cox, Timothy, Cox, Timothy M, T Cox, T M Cox, T. Cox, T. M. COX, T. M. Cox, T.M Cox

406

Publications

15K

Citations

H-Index

240

Concepts

All Affiliations

University of Cambridge Addenbrooke's Hospital Hammersmith Hospital University College London Amsterdam UMC Location University of Amsterdam

About

Timothy M. Cox is an author at University of Cambridge specializing in medicine, pathology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	91	5.9K
2	Health Sciences	9	9	276
3	Law	3	3	73
4	Engineering	2	2	61
5	Language Studies	1	1	40

Timothy M. Cox

166

Publications

11.5K

Citations

H-Index

Page 1

	Year	Citations
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis Timothy M. Cox, Robin Lachmann, C. E. Hollak, The Lancet Ogt 918BiosynthesisMedicineSubstrate BiosynthesisMicrobiology	2000	740
Mammalian AMP-activated Protein Kinase Subfamily David Stapleton, Ken I. Mitchelhill, Guang Gao, Journal of Biological Chemistry	1996	639
Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis Alison R. Hayman, Sheila J. Jones, A. Boyde, Development	1996	365
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention Rolf G. Boot, Marri Verhoek, Maaike de Fost, Blood	2003	333
THE ??-1,3-GALACTOSYLTRANSFERASE KNOCKOUT MOUSE Rick G. Tearle, Margaret J. Tange, Zara L. Zannettino, Transplantation	1996	307
Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10 Michael Allen, B. J. Myer, A.M. Khokher, QJM InflammationCytokineBone ThinningAutoimmune DiseaseGranulocyte	1997	242
Juvenile Hemochromatosis Locus Maps to Chromosome 1q Antonella Roetto, Antonio Totaro, Mario Cazzola, The American Journal of Human Genetics ChromatinCytogeneticsGeneticsChromosome BiologyMolecular Genetics	1999	239
Sustained therapeutic effects of oral miglustat (Zavesca, <i>N</i>‐butyldeoxynojirimycin, OGT 918) in type I Gaucher disease Deborah Elstein, Carla E. M. Hollak, Johannes M. F. G. Aerts, Journal of Inherited Metabolic Disease	2004	231
Iron binding proteins and influx of irom across the duodenal brush border Timothy M. Cox, Joël Mazurier, Geneviève Spik, Biochimica et Biophysica Acta (BBA) - General Subjects BiochemistryIron MetabolismMedicineHeme TransportIron Binding Proteins	1979	180
RIPK3 as a potential therapeutic target for Gaucher's disease Einat B. Vitner, Ran Salomon, Tamar Farfel‐Becker, Nature Medicine Potential Therapeutic TargetReceptor Tyrosine KinaseAutophagyPathologyCell Death	2014	158

Page 1